Ferric pyrophosphate citrate (Triferic™) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients

BACKGROUND: Administration of ferric pyrophosphate citrate (FPC, Triferic™) via hemodialysate may allow replacement of ongoing uremic and hemodialysis-related iron losses. FPC donates iron directly to transferrin, bypassing the reticuloendothelial system and avoiding iron sequestration. METHODS: Two...

Descripción completa

Detalles Bibliográficos
Autores principales: Fishbane, Steven N., Singh, Ajay K., Cournoyer, Serge H., Jindal, Kailash K., Fanti, Paolo, Guss, Carrie D., Lin, Vivian H., Pratt, Raymond D., Gupta, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
CLINICAL SCIENCE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656038/
https://www.ncbi.nlm.nih.gov/pubmed/26175145
http://dx.doi.org/10.1093/ndt/gfv277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656038/
https://www.ncbi.nlm.nih.gov/pubmed/26175145
http://dx.doi.org/10.1093/ndt/gfv277

Ejemplares similares